by Eric Christianson | Jun 26, 2024 | Clinical Pharmacy News and New Drug Updates, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I’ve encountered a significant proportion of patients who are on chronic benzodiazepines. Drug interactions, adverse effects, and other risks to my geriatric patient population are significant when using this class of medication. Benzodiazepine withdrawal is...
by Eric Christianson | Jun 9, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Bupropion (Wellbutrin) is an antidepressant that is most commonly used as an alternative (or sometimes in combination) to SSRIs. In this post, I will share my most important bupropion clinical pearls as well as some things that may show up on your board exam! Seizure...
by Eric Christianson | May 8, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
CD is a 50-year-old male presenting to your ambulatory care clinic to discuss vaping cessation. About three years ago, CD stopped smoking combustible tobacco cigarettes by transitioning to electronic cigarettes. Recently, he’s seen news articles about the unknown...
by Eric Christianson | May 5, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls, Women’s and Men’s Health Medication and Disease State Clinical Pearls
Is it safe for women to breastfeed while taking antidepressants? According to a CDC report from 2020, ~10.3% of women ages 18-39 take antidepressants, and the number of people diagnosed with depression and taking antidepressants continues to rise. In this article, we...
by Eric Christianson | May 1, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls, Women’s and Men’s Health Medication and Disease State Clinical Pearls
Depression is one of the top three health disorders in adults ages 18-34 with approximately 21.3% of these adults having depression. This means that many women suffer from depression during their peak childbearing years and will begin medication to treat it....
by Eric Christianson | Apr 17, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Trazodone belongs to a class of drugs called serotonin antagonist and reuptake inhibitors (SARIs). Although trazodone is only FDA-approved for the treatment of major depressive disorder (MDD), it is most often used off-label to manage insomnia. What’s interesting...
